Terms: = Prostate cancer AND PCM1, Q15154, PTC4, ENSG00000078674, 5108
14 results:
1. Genetically proxied glucose-lowering drug target perturbation and risk of cancer: a Mendelian randomisation analysis.
Yarmolinsky J; Bouras E; Constantinescu A; Burrows K; Bull CJ; Vincent EE; Martin RM; Dimopoulou O; Lewis SJ; Moreno V; Vujkovic M; Chang KM; Voight BF; Tsao PS; Gunter MJ; Hampe J; Pellatt AJ; Pharoah PDP; Schoen RE; Gallinger S; Jenkins MA; Pai RK; ; ; Gill D; Tsilidis KK
Diabetologia; 2023 Aug; 66(8):1481-1500. PubMed ID: 37171501
[TBL] [Abstract] [Full Text] [Related]
2. Do sex hormones confound or mediate the effect of chronotype on breast and prostate cancer? A Mendelian randomization study.
Hayes BL; Robinson T; Kar S; Ruth KS; Tsilidis KK; Frayling T; Murray A; Martin RM; Lawlor DA; Richmond RC
PLoS Genet; 2022 Jan; 18(1):e1009887. PubMed ID: 35061662
[TBL] [Abstract] [Full Text] [Related]
3. Genome-wide association study of serum prostate-specific antigen levels based on 1000 Genomes imputed data in Japanese: the Japan Multi-Institutional Collaborative Cohort Study.
Hishida A; Nakatochi M; Tamura T; Nagayoshi M; Okada R; Kubo Y; Tsukamoto M; Kadomatsu Y; Suzuki S; Nishiyama T; Kuriyama N; Watanabe I; Takezaki T; Nishimoto D; Kuriki K; Arisawa K; Katsuura-Kamano S; Mikami H; Kusakabe M; Oze I; Koyanagi YN; Nakamura Y; Kadota A; Shimanoe C; Tanaka K; Ikezaki H; Murata M; Kubo M; Momozawa Y; Takeuchi K; Wakai K;
Nagoya J Med Sci; 2021 Feb; 83(1):183-194. PubMed ID: 33727749
[TBL] [Abstract] [Full Text] [Related]
4. Pathologically Node-Positive prostate Carcinoma - Prevalence, Pattern of Care and Outcome From a Population-Based Study.
Roy S; Sia M; Tyldesley S; Bahl G
Clin Oncol (R Coll Radiol); 2019 Feb; 31(2):91-98. PubMed ID: 30389262
[TBL] [Abstract] [Full Text] [Related]
5. Genome-wide Scan Identifies Role for AOX1 in prostate cancer Survival.
Li W; Middha M; Bicak M; Sjoberg DD; Vertosick E; Dahlin A; Häggström C; Hallmans G; Rönn AC; Stattin P; Melander O; Ulmert D; Lilja H; Klein RJ
Eur Urol; 2018 Dec; 74(6):710-719. PubMed ID: 30289108
[TBL] [Abstract] [Full Text] [Related]
6. Genome-wide association study identifies variants in casein kinase II (CSNK2A2) to be associated with leukocyte telomere length in a Punjabi Sikh diabetic cohort.
Saxena R; Bjonnes A; Prescott J; Dib P; Natt P; Lane J; Lerner M; Cooper JA; Ye Y; Li KW; Maubaret CG; Codd V; Brackett D; Mirabello L; Kraft P; Dinney CP; Stowell D; Peyton M; Ralhan S; Wander GS; Mehra NK; Salpea KD; Gu J; Wu X; Mangino M; Hunter DJ; De Vivo I; Humphries SE; Samani NJ; Spector TD; Savage SA; Sanghera DK
Circ Cardiovasc Genet; 2014 Jun; 7(3):287-95. PubMed ID: 24795349
[TBL] [Abstract] [Full Text] [Related]
7. Genome-wide association scan for variants associated with early-onset prostate cancer.
Lange EM; Johnson AM; Wang Y; Zuhlke KA; Lu Y; Ribado JV; Keele GR; Li J; Duan Q; Li G; Gao Z; Li Y; Xu J; Isaacs WB; Zheng S; Cooney KA
PLoS One; 2014; 9(4):e93436. PubMed ID: 24740154
[TBL] [Abstract] [Full Text] [Related]
8. Commentary on "identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array." Eeles RA, Olama AA, Benlloch S, Saunders EJ, Leongamornlert DA, Tymrakiewicz M, Ghoussaini M, Luccarini C, Dennis J, Jugurnauth-Little S, Dadaev T, Neal DE, Hamdy FC, Donovan JL, Muir K, Giles GG, Severi G, Wiklund F, Gronberg H, Haiman CA, Schumacher F, Henderson BE, Le Marchand L, Lindstrom S, Kraft P, Hunter DJ, Gapstur S, Chanock SJ, Berndt SI, Albanes D, Andriole G, Schleutker J, Weischer M, Canzian F, Riboli E, Key TJ, Travis RC, Campa D, Ingles SA, John EM, Hayes RB, Pharoah PD, Pashayan N, Khaw KT, Stanford JL, Ostrander EA, Signorello LB, Thibodeau SN, Schaid D, Maier C, Vogel W, Kibel AS, Cybulski C, Lubinski J, Cannon-Albright L, Brenner H, Park JY, Kaneva R, Batra J, Spurdle AB, Clements JA, Teixeira MR, Dicks E, Lee A, Dunning AM, Baynes C, Conroy D, Maranian MJ, Ahmed S, Govindasami K, Guy M, Wilkinson RA, Sawyer EJ, Morgan A, Dearnaley DP, Horwich A, Huddart RA, Khoo VS, Parker CC, Van As NJ, Woodhouse CJ, Thompson A, Dudderidge T, Ogden C, Cooper CS, Lophatananon A, Cox A, Southey MC, Hopper JL, English DR, Aly M, Adolfsson J, Xu J, Zheng SL, Yeager M, Kaaks R, Diver WR, Gaudet MM, Stern MC, Corral R, Joshi AD, Shahabi A, Wahlfors T, Tammela TL, Auvinen A, Virtamo J, Klarskov P, Nordestgaard BG, Røder MA, Nielsen SF, Bojesen SE, Siddiq A, Fitzgerald LM, Kolb S, Kwon EM, Karyadi DM, Blot WJ, Zheng W, Cai Q, McDonnell SK, Rinckleb AE, Drake B, Colditz G, Wokolorczyk D, Stephenson RA, Teerlink C, Muller H, Rothenbacher D, Sellers TA, Lin HY, Slavov C, Mitev V, Lose F, Srinivasan S, Maia S, Paulo P, Lange E, Cooney KA, Antoniou AC, Vincent D, Bacot F, Tessier DC; COGS-cancer Research UK GWAS-ELLIPSE (part of GAME-ON) Initiative; Australian prostate cancer Bioresource; UK Genetic prostate cancer Study Collaborators/British Association of Urological Surgeons' Section of Oncology; UK ProtecT (prostate testing for cancer and Treatment) Study.
Olumi AF
Urol Oncol; 2014 Feb; 32(2):211. PubMed ID: 24445293
[TBL] [Abstract] [Full Text] [Related]
9. Phase II trial of neoadjuvant docetaxel and CG1940/CG8711 followed by radical prostatectomy in patients with high-risk clinically localized prostate cancer.
Vuky J; Corman JM; Porter C; Olgac S; Auerbach E; Dahl K
Oncologist; 2013 Jun; 18(6):687-8. PubMed ID: 23740935
[TBL] [Abstract] [Full Text] [Related]
10. Side-fenestrated catheter decreases leakage at the urethrovesical anastomosis after robot-assisted laparoscopic radical prostatectomy.
Riikonen J; Kaipia A; Matikainen M; Koskimäki J; Kylmälä T; Tammela TL
Scand J Urol; 2014 Feb; 48(1):21-6. PubMed ID: 23495792
[TBL] [Abstract] [Full Text] [Related]
11. Combined immunotherapy with granulocyte-macrophage colony-stimulating factor-transduced allogeneic prostate cancer cells and ipilimumab in patients with metastatic castration-resistant prostate cancer: a phase 1 dose-escalation trial.
van den Eertwegh AJ; Versluis J; van den Berg HP; Santegoets SJ; van Moorselaar RJ; van der Sluis TM; Gall HE; Harding TC; Jooss K; Lowy I; Pinedo HM; Scheper RJ; Stam AG; von Blomberg BM; de Gruijl TD; Hege K; Sacks N; Gerritsen WR
Lancet Oncol; 2012 May; 13(5):509-17. PubMed ID: 22326922
[TBL] [Abstract] [Full Text] [Related]
12. Risk of malignancy in patients with schizophrenia or bipolar disorder: nested case-control study.
Hippisley-Cox J; Vinogradova Y; Coupland C; Parker C
Arch Gen Psychiatry; 2007 Dec; 64(12):1368-76. PubMed ID: 18056544
[TBL] [Abstract] [Full Text] [Related]
13. Results of high dose rate afterloading brachytherapy boost to conventional external beam radiation therapy for initial and locally advanced prostate cancer.
Pellizzon AC; Nadalin W; Salvajoli JV; Fogaroli RC; Novaes PE; Maia MA; Ferrigno R
Radiother Oncol; 2003 Feb; 66(2):167-72. PubMed ID: 12648788
[TBL] [Abstract] [Full Text] [Related]
14. Sigma-1 and sigma-2 receptors are expressed in a wide variety of human and rodent tumor cell lines.
Vilner BJ; John CS; Bowen WD
Cancer Res; 1995 Jan; 55(2):408-13. PubMed ID: 7812973
[TBL] [Abstract] [Full Text] [Related]
